0000903129false00009031292024-10-302024-10-30

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 30, 2024

 

 

GENTHERM INCORPORATED

(Exact name of Registrant as Specified in Its Charter)

 

 

Michigan

0-21810

95-4318554

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

21680 Haggerty Road

 

Northville, Michigan

 

48167

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (248) 504-0500

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, no par value

 

THRM

 

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

Item 2.02 Results of Operations and Financial Condition.

On October 30, 2024, Gentherm Incorporated (the “Company”) publicly announced its financial results for the third quarter of 2024 and updated 2024 guidance. A copy of the Company’s news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On October 30, 2024 at 8:00 a.m. Eastern Time, the Company will host a conference call to discuss the third quarter of 2024 financial results. A copy of the supplemental materials that will be used during the conference call is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

The information in Items 2.02 and 7.01 herein and the attached exhibits 99.1 and 99.2 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly stated by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit 99.1

Company news release dated October 30, 2024 concerning financial results

Exhibit 99.2

Supplemental materials dated October 30, 2024

Exhibit 104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

GENTHERM INCORPORATED

 

 

 

 

By:

 

/s/ Wayne Kauffman

 

 

 

Wayne Kauffman

 

 

 

Senior Vice President, General Counsel and Secretary

Date: October 30, 2024

 

 

 

 


 

img17760854_0.jpg

 

Exhibit 99.1

Gentherm Reports 2024 Third Quarter Results

Strong Outperformance Over Light Vehicle Production

Secured Third Quarter Record $600 Million in Automotive New Business Awards

Updates 2024 Guidance

NORTHVILLE, Michigan, October 30, 2024 /Global Newswire/ -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced its financial results for the third quarter ending September 30, 2024.

Third Quarter Highlights

 

Product revenues of $371.5 million increased 1.5% from $366.2 million in the third quarter of 2023. Excluding the impact of foreign currency translation, product revenues increased 1.0% year over year
Automotive revenues increased 1.1% year over year; excluding the impact of foreign currency translation, automotive revenues increased 0.7% year over year
GAAP diluted earnings per share was $0.51 as compared with $0.48 for the prior-year period
Adjusted diluted earnings per share (see table herein) was $0.75. Adjusted diluted earnings per share in the prior-year period was $0.64
Secured automotive new business awards totaling $600 million in the quarter

 

Phil Eyler, the Company's President and CEO, said, “The financial and operating results of the third quarter reflect the continued momentum of our strategy to bring innovation and unique solutions to our customers. Our Automotive Climate and Comfort Solutions revenue outperformed actual light vehicle production in our key markets by nearly 800 basis points. We achieved quarterly automotive new business awards of $600 million, a third quarter record, keeping us on track for annual awards of over $2 billion for the second consecutive year.

He added, “We continue to execute on securing awards and launching new programs, particularly for our new innovative solutions. We had our first market launch of ClimateSense® with a five-zone micro-climate solution on the Cadillac Escalade IQ. Additionally, we won an award for ComfortScale™, our patented, next generation integrated thermal, lumbar and massage system. We have seen an acceleration of new technology wins that we expect will fuel future growth.

He concluded, “Year to date, our relentless focus on operational excellence and financial discipline has yielded not only continued growth over market, but also a nearly 100 basis point expansion in Adjusted EBITDA margin. Including share repurchases in the quarter, we returned more than $100 million dollars to shareholders through share repurchases in the last twelve months. I would like to thank the Gentherm team for their unwavering efforts to drive our business and generate shareholder returns.”

2024 Third Quarter Financial Review

 

Product revenues for the third quarter of 2024 increased by $5.3 million, or 1.5%, as compared with the prior-year period. Excluding the impact of foreign currency translation, product revenues increased 1.0% year over year.

Automotive revenues increased 1.1% year over year. Adjusting for foreign currency translation, phasing out the non-automotive and contract manufacturing electronics business as well as one-time benefits from recoveries in both periods, Automotive revenues increased 1.2% year over year. Revenues from

 


 

img17760854_0.jpg

 

Automotive Climate and Comfort Solutions increased 3.3% in the third quarter compared to the prior-year period.

According to S&P Global Mobility’s mid-October report, actual light vehicle production decreased by 4.5% in the third quarter when compared with the same quarter of 2023 in the Company’s key markets of North America, Europe, China, Japan, and Korea.

Gentherm Medical revenue increased 11.3% year over year, primarily as a result of higher Blanketrol® sales in the U.S., and Astopad® in Europe. Adjusting for the impact of foreign currency translation, Medical revenues increased 10.4%.

See the “Revenues by Product Category and Reconciliation of Foreign Currency Translation Impact” table included below for additional detail.

Gross margin rate increased to 25.5% in the current-year period, as compared with 23.5% in the prior-year period. The increase from the prior-year period was driven by Fit-for-Growth 2.0 initiatives including supplier cost reductions, value engineering activities, as well as the impact of our previously announced exit of the non-automotive electronics business. These were partially offset by annual price reductions and start-up costs from our new plants opening in Monterrey, Mexico and Tangier, Morrocco.

Net research and development expenses of $23.0 million in the quarter were relatively unchanged compared to the prior-year period.

Selling, general and administrative expenses of $36.9 million in the quarter decreased $1.4 million, or 3.6%, versus the prior-year period. The year-over-year decrease was primarily driven by acquisition and integration expenses in the prior year.

Restructuring expenses, net of $2.7 million in the current-year period increased $1.6 million, versus the prior-year period primarily as a result of discrete restructuring activities associated with the Company’s Fit-for-Growth 2.0 initiatives and previously announced footprint optimization.

As described more fully in the “Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDA Margin” table included below, the Company recorded Adjusted EBITDA of $48.1 million in the quarter compared with $47.7 million in the prior-year period, an increase of $0.4 million or 0.9%.

Income tax expense in the quarter was $3.4 million, as compared with $6.9 million in the prior-year period. The effective tax rate was approximately 18% in the quarter.

GAAP diluted earnings per share for the quarter was $0.51 compared with $0.48 for the prior-year period. Adjusted diluted earnings per share, excluding restructuring expenses, net, non-cash purchase accounting impact, non-automotive electronics inventory benefit, unrealized currency loss, and other items specified on the table below, was $0.75. Adjusted diluted earnings per share in the prior-year period was $0.64.

The Company provides various non-GAAP financial measures in this release. See “Use of Non-GAAP Measures” below for additional information, including definitions, usefulness for investors and limitations, as well as reconciliations below to the most directly comparable GAAP financial measures.

 


 

img17760854_0.jpg

 

Guidance

 

The Company’s full-year 2024 guidance as of October 30, 2024 is shown below:

 

 

As of July 31, 2024

 

As of October 30, 2024 (1)

Product Revenues

 

Low end of $1.5B – $1.6B

 

$1.45B – $1.47B

Adjusted EBITDA Margin Rate

 

Above mid-point of 12.5% – 13.5%

 

Near mid-point of 12.5% – 13.5%

Full-year Adjusted Effective Tax Rate

 

26% – 29%

 

No change

Capital Expenditures

 

$65M – $75M

 

No change

(1)
Based on the current forecast of customer orders, our expectations of near-term conditions, and light vehicle production in our relevant markets decreasing at low to mid-single digit rate for full year 2024 versus 2023, and a EUR to USD exchange rate of $1.08/Euro.

Conference Call

As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside this U.S.). The passcode for the live call is 13749599.

A live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.

A telephonic replay will be available at approximately two hours after the call until 11:59 pm Eastern Time on November 13, 2024. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13749599.

Investor Contact
Gregory Blanchette
investors@gentherm.com
248.308.1702

Media Contact
Melissa Fischer
media@gentherm.com
248.289.9702

About Gentherm

Gentherm (NASDAQ: THRM) is the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats®, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, Morocco, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.

 

 


 

img17760854_0.jpg

 

Forward-Looking Statements

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors we consider appropriate under the circumstances. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:

macroeconomic, geopolitical and similar global factors in the cyclical Automotive industry;
increasing U.S. and global competition, including with non-traditional entrants;
our ability to effectively manage new product launches and research and development, and the market acceptance of such products and technologies;
the evolution and recent challenges of the automotive industry towards electric vehicles, autonomous vehicles and mobility on demand services, and related consumer behaviors and preferences;
our ability to convert automotive new business awards into product revenues;
the recent supply-constrained environment, and inflationary and other cost pressures;
the production levels of our major customers and OEMs in our key markets and sudden fluctuations in such production levels;
our business in China, which is subject to unique operational, competitive, regulatory and economic risks;
our ability to attract and retain highly skilled employees and wage inflation;
a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, such as recent labor strikes among certain OEMs and suppliers;
our achievement of product cost reductions to offset customer-imposed price reductions or other pricing pressures;
our product quality and safety and impact of product safety recalls and alleged defects in products;
our ability to execute efforts to optimize our global supply chain and manufacturing footprint, including opening new facilities and transferring production;
our ability to integrate our recent acquisitions and realize synergies, as well as to consummate additional strategic acquisitions, investments and exits, and achieve planned benefits;
any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks;
the impact of our global operations, including our global supply chain, operations within Ukraine, economic and trade policies, and foreign currency and exchange risk;
any loss or insolvency of our key customers and OEMs, or key suppliers;
our ability to project future sales volume based on third-party information, based on which we manage our business;
the protection of our intellectual property in certain jurisdictions;
our compliance with anti-corruption laws and regulations;
legal and regulatory proceedings and claims involving us or one of our major customers;
the extensive regulation of our patient temperature management business;
risks associated with our manufacturing processes;

 


 

img17760854_0.jpg

 

the effects of climate change and catastrophic events, as well as regulatory and stakeholder-imposed requirements to address climate change and other sustainability issues;
our product quality and safety;
our borrowing availability under our revolving credit facility, as well ability to access the capital markets, to support our planned growth; and
our indebtedness and compliance with our debt covenants.

The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.

Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Use of Non-GAAP Financial Measures

 

In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding: adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); free cash flow; Net Debt, revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; Automotive Climate and Comfort Solutions revenues; and adjusted operating expenses, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock based compensation expenses, and other gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expenses, net, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted EPS as earnings adjusted by gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expenses, net, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Free Cash Flow as Net cash provided by operating activities less Purchases of property and equipment. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines revenue, segment revenue or product revenue excluding foreign currency translation and other specified gains and losses as such revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates and excluding the other items specified in the reconciliation tables herein. The Company defines Automotive Climate and Comfort Solutions revenues as Automotive revenue excluding specified product revenues and the impact of non-automotive electronics and contract manufacturing electronics revenues. The Company defines adjusted operating expenses as operating expenses excluding impairment of intangible assets and property and equipment, restructuring expenses, net, related non-cash stock based compensation, acquisition, integration and divestiture expenses.

The Company’s reconciliations are included in this release or can be found in the supplemental materials furnished as Exhibit 99.2 to the Company’s Form 8-K dated October 30, 2024.

 


 

img17760854_0.jpg

 

In evaluating its business, the Company considers and uses Free Cash Flow and Net Debt as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income (loss), revenue or other consolidated income statement or cash flow statement data prepared in accordance with GAAP.

Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EPS. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

 


 

img17760854_0.jpg

 

 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(Dollars in thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Product revenues

 

$

371,512

 

 

$

366,195

 

 

$

1,103,210

 

 

$

1,102,143

 

Cost of sales

 

 

276,639

 

 

 

279,985

 

 

 

822,883

 

 

 

846,815

 

Gross margin

 

 

94,873

 

 

 

86,210

 

 

 

280,327

 

 

 

255,328

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Net research and development expenses

 

 

23,013

 

 

 

23,150

 

 

 

67,619

 

 

 

72,991

 

Selling, general and administrative expenses

 

 

36,861

 

 

 

38,220

 

 

 

116,992

 

 

 

113,680

 

Restructuring expenses, net

 

 

2,662

 

 

 

1,099

 

 

 

12,342

 

 

 

3,412

 

Impairment of goodwill

 

 

 

 

 

 

 

 

 

 

 

19,509

 

Total operating expenses

 

 

62,536

 

 

 

62,469

 

 

 

196,953

 

 

 

209,592

 

Operating income

 

 

32,337

 

 

 

23,741

 

 

 

83,374

 

 

 

45,736

 

Interest expense, net

 

 

(4,710

)

 

 

(3,368

)

 

 

(11,956

)

 

 

(9,444

)

Foreign currency (loss) gain

 

 

(8,480

)

 

 

2,107

 

 

 

(6,213

)

 

 

384

 

Other income

 

 

263

 

 

 

272

 

 

 

952

 

 

 

1,058

 

Earnings before income tax

 

 

19,410

 

 

 

22,752

 

 

 

66,157

 

 

 

37,734

 

Income tax expense

 

 

3,445

 

 

 

6,908

 

 

 

16,531

 

 

 

15,478

 

Net income

 

$

15,965

 

 

$

15,844

 

 

$

49,626

 

 

$

22,256

 

Basic earnings per share

 

$

0.51

 

 

$

0.48

 

 

$

1.58

 

 

$

0.67

 

Diluted earnings per share

 

$

0.51

 

 

$

0.48

 

 

$

1.57

 

 

$

0.67

 

Weighted average number of shares – basic

 

 

31,187

 

 

 

32,944

 

 

 

31,421

 

 

 

33,049

 

Weighted average number of shares – diluted

 

 

31,365

 

 

 

33,196

 

 

 

31,605

 

 

 

33,311

 

 

 

 

 


 

img17760854_0.jpg

 

GENTHERM INCORPORATED

REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT

(Dollars in thousands)

(Unaudited)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

% Change

 

 

2024

 

 

2023

 

 

% Change

 

Climate Control Seat

 

$

115,498

 

 

$

124,905

 

 

(7.5

)%

 

$

352,789

 

 

$

360,868

 

 

 

(2.2

)%

Seat Heaters

 

 

72,982

 

 

 

77,238

 

 

(5.5

)%

 

 

227,114

 

 

 

231,132

 

 

 

(1.7

)%

Lumbar and Massage Comfort Solutions

 

 

48,970

 

 

 

33,260

 

 

47.2

 %

 

 

133,090

 

 

 

109,602

 

 

 

21.4

 %

Steering Wheel Heaters

 

 

44,711

 

 

 

39,861

 

 

12.2

 %

 

 

126,939

 

 

 

115,166

 

 

 

10.2

 %

Valve Systems

 

 

26,082

 

 

 

27,830

 

 

(6.3

)%

 

 

81,974

 

 

 

82,516

 

 

 

(0.7

)%

Automotive Cables

 

 

16,834

 

 

 

19,668

 

 

(14.4

)%

 

 

57,185

 

 

 

60,131

 

 

 

(4.9

)%

Battery Performance Solutions

 

 

16,869

 

 

 

17,242

 

 

(2.2

)%

 

 

46,540

 

 

 

57,138

 

 

 

(18.5

)%

Electronics

 

 

10,862

 

 

 

10,163

 

 

6.9

 %

 

 

26,218

 

 

 

30,456

 

 

 

(13.9

)%

Other Automotive

 

 

5,996

 

 

 

4,615

 

 

29.9

 %

 

 

15,595

 

 

 

21,998

 

 

 

(29.1

)%

Subtotal Automotive segment

 

 

358,804

 

 

 

354,782

 

 

1.1

 %

 

 

1,067,444

 

 

 

1,069,007

 

 

 

(0.1

)%

Medical segment

 

 

12,708

 

 

 

11,413

 

 

11.3

 %

 

 

35,766

 

 

 

33,136

 

 

 

7.9

 %

Total Company

 

$

371,512

 

 

$

366,195

 

 

1.5

 %

 

$

1,103,210

 

 

$

1,102,143

 

 

 

0.1

 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation impact (a)

 

 

1,599

 

 

 

 

 

 

 

 

(5,134

)

 

 

 

 

 

 

Total Company, excluding foreign
currency translation impact

 

$

369,913

 

 

$

366,195

 

 

1.0

 %

 

$

1,108,344

 

 

$

1,102,143

 

 

 

0.6

 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Foreign currency translation impacts for the Automotive segment and Medical segment were $1,487 and $112 respectively, for the three months ended September 30, 2024. Foreign currency translation impacts for the Automotive segment and Medical segment were $(5,129) and $(5) respectively, for the nine months ended September 30, 2024.

 

 

 


 

img17760854_0.jpg

 

 

GENTHERM INCORPORATED

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA

AND ADJUSTED EBITDA MARGIN

(Dollars in thousands)

(Unaudited)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net income

 

$

15,965

 

 

$

15,844

 

 

$

49,626

 

 

$

22,256

 

Add back:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

12,351

 

 

 

12,516

 

 

 

38,742

 

 

 

38,354

 

Income tax expense (a)

 

 

3,445

 

 

 

6,908

 

 

 

16,531

 

 

 

15,478

 

Interest expense, net (b)

 

 

4,710

 

 

 

3,368

 

 

 

11,956

 

 

 

9,444

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash stock based compensation (c)

 

 

2,927

 

 

 

3,421

 

 

 

10,334

 

 

 

8,592

 

Restructuring expenses, net

 

 

2,662

 

 

 

1,099

 

 

 

12,342

 

 

 

3,412

 

Non-automotive electronics inventory (benefit) charge

 

 

(2,679

)

 

 

3,426

 

 

 

(4,451

)

 

 

5,489

 

Unrealized currency loss (gain)

 

 

8,604

 

 

 

(898

)

 

 

6,251

 

 

 

4,227

 

Acquisition and integration expenses

 

 

 

 

 

1,618

 

 

 

 

 

 

4,730

 

Impairment of goodwill

 

 

 

 

 

 

 

 

 

 

 

19,509

 

Other

 

 

118

 

 

 

372

 

 

 

187

 

 

 

71

 

Adjusted EBITDA

 

$

48,103

 

 

$

47,674

 

 

$

141,518

 

 

$

131,562

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

371,512

 

 

$

366,195

 

 

$

1,103,210

 

 

$

1,102,143

 

Net income margin

 

 

4.3

%

 

 

4.3

%

 

 

4.5

%

 

 

2.0

%

Adjusted EBITDA margin

 

 

12.9

%

 

 

13.0

%

 

 

12.8

%

 

 

11.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Includes $2,423 of deferred income tax benefit associated with the goodwill impairment of the Medical reporting unit for the nine months ended September 30, 2023.

 

(b) Includes $1,157 and $1,161 of interest expense for the three and nine months ended September 30, 2024, related to mark-to-market adjustment of our floating-to-fixed interest rate swap agreement with a notional amount of $100,000.

 

(c) Includes operating expenses of $2,708 and $3,384 for the three months ended September 30, 2024 and 2023, respectively. Includes operating expenses of $9,717 and $8,218 for the nine months ended September 30, 2024 and 2023, respectively.

 

 

 


 

img17760854_0.jpg

 

GENTHERM INCORPORATED

RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME

AND ADJUSTED EARNINGS PER SHARE

(Dollars in thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net income

 

$

15,965

 

 

$

15,844

 

 

$

49,626

 

 

$

22,256

 

Non-cash purchase accounting impact

 

 

1,608

 

 

 

1,613

 

 

 

4,797

 

 

 

5,793

 

Restructuring expenses, net

 

 

2,662

 

 

 

1,099

 

 

 

12,342

 

 

 

3,412

 

Unrealized currency loss (gain)

 

 

8,604

 

 

 

(898

)

 

 

6,251

 

 

 

4,227

 

Non-automotive electronics inventory (benefit) charge

 

 

(2,679

)

 

 

3,426

 

 

 

(4,451

)

 

 

5,489

 

Acquisition and integration expenses

 

 

 

 

 

1,618

 

 

 

 

 

 

4,730

 

Impairment of goodwill

 

 

 

 

 

 

 

 

 

 

 

19,509

 

Other

 

 

118

 

 

 

372

 

 

 

187

 

 

 

71

 

Tax effect of above

 

 

(2,695

)

 

 

(1,693

)

 

 

(4,546

)

 

 

(8,635

)

Adjusted net income

 

$

23,583

 

 

$

21,381

 

 

$

64,206

 

 

$

56,852

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

31,187

 

 

 

32,944

 

 

 

31,421

 

 

 

33,049

 

Diluted

 

 

31,365

 

 

 

33,196

 

 

 

31,605

 

 

 

33,311

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share, as reported:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.51

 

 

$

0.48

 

 

$

1.58

 

 

$

0.67

 

Diluted

 

$

0.51

 

 

$

0.48

 

 

$

1.57

 

 

$

0.67

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.76

 

 

$

0.65

 

 

$

2.04

 

 

$

1.72

 

Diluted

 

$

0.75

 

 

$

0.64

 

 

$

2.03

 

 

$

1.71

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

img17760854_0.jpg

 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED BALANCE SHEETS

(Dollars in thousands, except share data)

(Unaudited)

 

 

 

September 30, 2024

 

 

December 31, 2023

 

ASSETS

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

150,581

 

 

$

149,673

 

Accounts receivable, net

 

 

270,913

 

 

 

253,579

 

Inventory:

 

 

 

 

 

 

Raw materials

 

 

141,547

 

 

 

126,013

 

Work in process

 

 

20,116

 

 

 

15,704

 

Finished goods

 

 

72,083

 

 

 

64,175

 

Inventory, net

 

 

233,746

 

 

 

205,892

 

Other current assets

 

 

81,711

 

 

 

78,420

 

Total current assets

 

 

736,951

 

 

 

687,564

 

Property and equipment, net

 

 

253,531

 

 

 

245,234

 

Goodwill

 

 

104,839

 

 

 

104,073

 

Other intangible assets, net

 

 

61,067

 

 

 

66,482

 

Operating lease right-of-use assets

 

 

29,366

 

 

 

27,358

 

Deferred income tax assets

 

 

81,923

 

 

 

81,930

 

Other non-current assets

 

 

30,502

 

 

 

21,730

 

Total assets

 

$

1,298,179

 

 

$

1,234,371

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

Accounts payable

 

$

254,555

 

 

$

215,827

 

Current lease liabilities

 

 

7,038

 

 

 

7,700

 

Current maturities of long-term debt

 

 

210

 

 

 

621

 

Other current liabilities

 

 

103,647

 

 

 

100,805

 

Total current liabilities

 

 

365,450

 

 

 

324,953

 

Long-term debt, less current maturities

 

 

222,104

 

 

 

222,217

 

Non-current lease liabilities

 

 

21,929

 

 

 

16,175

 

Pension benefit obligation

 

 

2,805

 

 

 

3,209

 

Other non-current liabilities

 

 

25,182

 

 

 

23,095

 

Total liabilities

 

$

637,470

 

 

$

589,649

 

Shareholders’ equity:

 

 

 

 

 

 

Common Stock:

 

 

 

 

 

 

No par value; 55,000,000 shares authorized 30,976,821 and 31,542,001 issued and outstanding at September 30, 2024 and December 31, 2023, respectively

 

 

10,698

 

 

 

50,503

 

Paid-in capital

 

 

4,552

 

 

 

 

Accumulated other comprehensive loss

 

 

(35,021

)

 

 

(30,160

)

Accumulated earnings

 

 

680,480

 

 

 

624,379

 

Total shareholders’ equity

 

 

660,709

 

 

 

644,722

 

Total liabilities and shareholders’ equity

 

$

1,298,179

 

 

$

1,234,371

 

 

 


 

img17760854_0.jpg

 

GENTHERM INCORPORATED

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

Operating Activities:

 

 

 

 

 

 

Net income

 

$

49,626

 

 

$

22,256

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

40,085

 

 

 

38,531

 

Deferred income taxes

 

 

1,568

 

 

 

(3,017

)

Stock based compensation

 

 

10,291

 

 

 

8,451

 

(Gain) loss on disposition of property and equipment

 

 

(1,702

)

 

 

873

 

Provisions for inventory

 

 

502

 

 

 

6,597

 

Impairment of goodwill

 

 

 

 

 

19,509

 

Other

 

 

(1,057

)

 

 

81

 

Changes in assets and liabilities:

 

 

 

 

 

 

Accounts receivable, net

 

 

(16,179

)

 

 

(19,813

)

Inventory

 

 

(27,826

)

 

 

3,733

 

Other assets

 

 

(35,959

)

 

 

(19,218

)

Accounts payable

 

 

38,501

 

 

 

32,158

 

Other liabilities

 

 

15,239

 

 

 

(10,099

)

Net cash provided by operating activities

 

 

73,089

 

 

 

80,042

 

Investing Activities:

 

 

 

 

 

 

Purchases of property and equipment

 

 

(50,354

)

 

 

(26,526

)

Proceeds from the sale of property and equipment

 

 

7,537

 

 

 

72

 

Proceeds from deferred purchase price of factored receivables

 

 

10,266

 

 

 

10,139

 

Cost of technology investments

 

 

(590

)

 

 

(630

)

Net cash used in investing activities

 

 

(33,141

)

 

 

(16,945

)

Financing Activities:

 

 

 

 

 

 

Borrowings on debt

 

 

53,000

 

 

 

 

Repayments of debt

 

 

(53,520

)

 

 

(27,166

)

Proceeds from the exercise of Common Stock options

 

 

4,650

 

 

 

263

 

Taxes withheld and paid on employees' stock based compensation

 

 

(3,157

)

 

 

(2,754

)

Cash paid for the repurchase of Common Stock

 

 

(41,578

)

 

 

(31,094

)

Net cash used in financing activities

 

 

(40,605

)

 

 

(60,751

)

Foreign currency effect

 

 

1,565

 

 

 

(1,883

)

Net increase in cash and cash equivalents

 

 

908

 

 

 

463

 

Cash and cash equivalents at beginning of period

 

 

149,673

 

 

 

153,891

 

Cash and cash equivalents at end of period

 

$

150,581

 

 

$

154,354

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

Cash paid for taxes

 

$

19,470

 

 

$

18,893

 

Cash paid for interest

 

 

10,022

 

 

 

9,737

 

 

 

 

 

 

 


 

img17760854_0.jpg

 

GENTHERM INCORPORATED

OTHER NON-GAAP RECONCILIATIONS

(Dollars in thousands)

(Unaudited)

 

 

 

Three Months Ended September 30,

 

 

 

2024

 

 

2023

 

Automotive revenues

 

$

358,804

 

 

$

354,782

 

Non-automotive electronics revenues and contract manufacturing electronics

 

 

5,985

 

 

 

7,321

 

One-time benefits from recoveries and retrofits

 

 

 

 

 

140

 

Adjusted Automotive revenues

 

 

352,819

 

 

 

347,321

 

Foreign currency translation impact

 

 

1,467

 

 

 

 

Adjusted Automotive revenues, excluding foreign currency translation impact

 

$

351,352

 

 

$

347,321

 

Year over Year % change

 

 

1.2

 %

 

 

 

 

 

 

Three Months Ended September 30,

 

 

 

2024

 

 

2023

 

Automotive revenues

 

$

358,804

 

 

$

354,782

 

Less: Valve Systems

 

 

26,082

 

 

 

27,830

 

Less: Automotive Cables

 

 

16,834

 

 

 

19,668

 

Less: Battery Performance Solutions

 

 

16,869

 

 

 

17,242

 

Less: Non-automotive and contract manufacturing electronics

 

 

5,985

 

 

 

7,321

 

Automotive Climate and Comfort Solutions revenues

 

 

293,034

 

 

 

282,721

 

Less: One-time benefits from recoveries and retrofits

 

 

 

 

 

140

 

Adjusted Automotive Climate and Comfort Solutions revenues

 

 

293,034

 

 

 

282,581

 

Foreign currency translation impact

 

 

1,024

 

 

 

 

Adjusted Automotive Climate and Comfort Solutions revenues, excluding foreign currency translation impact

 

$

292,010

 

 

$

282,581

 

Year over Year % change

 

 

3.3

 %

 

 

 

 

 


Slide 1

Proprietary © Gentherm 2024 2024 Third Quarter Results October 30, 2024 Exhibit 99.2


Slide 2

Use of Non-GAAP Financial Measures* In addition to the results reported herein in accordance with GAAP, the Company has provided here or may discuss on the related conference call adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); free cash flow; Net Debt; revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; Automotive Climate and Comfort Solutions revenues; and adjusted operating expenses, each a non-GAAP financial measure. See the Company’s earnings release dated October 30, 2024, for the definitions of each non-GAAP financial measure, information regarding why the Company utilizes such non-GAAP measures as supplemental measures of performance or liquidity, and their limitations, and for certain reconciliations of GAAP to non-GAAP historical financial measures. * See Appendix for certain reconciliations of GAAP to non-GAAP historical financial measures. Proprietary © Gentherm 2024


Slide 3

Forward-Looking Statements Proprietary © Gentherm 2024 Except for historical information contained herein, statements in this presentation are forward-looking statements that are made by Gentherm Incorporated (the “Company”) pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements that address future operating, financial or business performance or strategies or expectations are forward-looking statements. The forward-looking statements included in this presentation are made as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors we consider appropriate under the circumstances. Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. The forward-looking statements are subject to a number of important assumptions, risks, uncertainties and other factors that may cause actual results or performance to differ materially from that expressed or implied by such statements. For a discussion of these risks and uncertainties and other factors, please see the Company’s most recent Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission, including “Risk Factors.” In addition, the business outlook discussed in this presentation does not include the potential impact of any business combinations, acquisitions, divestitures, strategic investments and other significant transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.


Slide 4

2024 Priorities Proprietary © Gentherm 2024 4 Laser focused on key priorities to drive operational execution, profitability improvement and innovation ​Execute on Fit-for-Growth 2.0 initiatives to expand margin Deliver industry leading proprietary innovations such as ClimateSense®, WellSenseTM and ComfortScaleTM 03 Lead the industry with Automotive New Business Awards and execute on unprecedented award backlog​


Slide 5

Automotive Highlights 30 Vehicle launches with 11 OEMs Multiple CCS® Launches Proprietary © Gentherm 2024 5 The DEI Employer® Awards, & Reuters D.R.I.V.E. Honours 2024 Empowering Women Award ClimateSense® launch on Cadillac Escalade IQ Record quarterly revenue for pneumatic lumbar and massage solutions Cadillac Escalade IQ Kia K4 BMW 5-Series Skoda Kodiaq Audi A5 Volkswagen Passat Pro Yangwang U9 Volkswagen Magotan


Slide 6

New Automotive Business Awards $600M in awards in 3Q Honda Pilot EV heated interior award Proprietary © Gentherm 2024 6 Continued strong demand for thermal comfort, massage and lumbar solutions CCS® Awards from: Hyundai | Honda | Toyota | Audi Large EV Manufacturer | Great Wall Expanding business with Chinese Domestic OEMs including Leap Motor and Xiaomi’s Mi Auto 13 Steering Wheel Heater Awards, including 8 hands-on-detection enabled awards, including the GM Full Size Truck and Large SUV platforms


Slide 7

First ComfortScale™ Award Our patented, fully integrated, modular thermal and pneumatic lumbar and massage solution creates customer value and adds content per vehicle General Motors: Truck platform including Chevrolet Silverado & GMC Sierra PCS™ Lumbar Support PCS™ Massage CCS® Vent CCS® Heat Multifunction ECU ClimateSense® Software Proprietary © Gentherm 2024 7 01 Flexible design provides ability to be foam and seat agnostic, adaptable for all OEMs and Seat Tier 1’s 03 Scalable system from lumbar only to fully contented pneumatic and thermal solutions 02 Unmatched performance with demonstratable improvement in time to occupant comfort resulting in an enhanced user experience 04 Easy and quick to integrate design enables running changes 05 Lower cost and complexity reducing seat assembly time for JIT partners CCI™ Steering Wheel Heat


Slide 8

Medical Highlights Proprietary © Gentherm 2024 8 Proprietary © Gentherm 2024 8 Year-over-year revenue growth Quarterly revenue increased 10%, ex-fx Strong growth of flagship Blanketrol continues in the U.S., highlighted by a key win with the U.S. Navy Driving organic revenue growth and improved profitability Strong partner execution in Europe, Middle East & Africa continues to produce growth in the Region


Slide 9

(Dollars in thousands, except per share data) 2024 2023 2024 2023 Product Revenues $ 371,512 $ 366,195 $ 1,103,210 $ 1,102,143   Automotive 358,804 354,782 1,067,444 1,069,007   Medical 12,708 11,413 35,766 33,136 Gross Margin 94,873 86,210 280,327 255,328 Gross Margin % 25.5 % 23.5 % 25.4 % 23.2 % Operating Expenses 62,536 62,469 196,953 209,592 Operating Income 32,337 23,741 83,374 45,736 Adjusted EBITDA 48,103 47,674 141,518 131,562 Adjusted EBITDA Margin 12.9 % 13.0 % 12.8 % 11.9 % Diluted EPS - As Adjusted $ 0.75 $ 0.64 $ 2.03 $ 1.71 Select Income Statement Data Proprietary © Gentherm 2024 9 Three Months Ended September 30 Nine Months Ended September 30


Slide 10

Select Balance Sheet Data September 30, 2024 June 30, 2023 December 31, 2023 December 31, 2022 December 31, 2022 Cash and Cash Equivalents $ 150,581 $ 149,673 Total Assets  1,298,179 1,234,371 Debt 222,314 222,838    Current 210 621    Non-Current 222,104 222,217 Revolving LOC Availability 278,000 278,000 Total Liquidity 428,581 427,673 Proprietary © Gentherm 2024 10 (Dollars in thousands)


Slide 11

Proprietary © Gentherm 2024 11 2024 Guidance As of July 31, 2024 As of October 30, 2024(1) Product Revenues Low end of $1.5B - $1.6B $1.45B – $1.47B Adjusted EBITDA Margin Rate Above mid-point of 12.5% - 13.5% Near mid-point of 12.5% – 13.5% Adjusted Effective Tax Rate 26% - 29% No change Capital Expenditures $65M - $75M No change Based on the current forecast of customer orders, our expectations of near-term conditions, and light vehicle production in our relevant markets decreasing at low to mid single digit rate for full year 2024 versus 2023, and a EUR to USD exchange rate of $1.08/Euro. Due to the inherent difficulty of forecasting the timing and amount of certain items that would impact net income margin, such as foreign currency gains and losses, we are unable to reasonably estimate net income margin, the GAAP financial measure most directly comparable to Adjusted EBITDA margin. Accordingly, we are unable to provide a reconciliation of Adjusted EBITDA margin to net income margin with respect to the guidance provided.


Slide 12

Appendix Proprietary © Gentherm 2024


Slide 13

Proprietary © Gentherm 2024 13 Reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin Three Months Ended September 30 2024 2023 2024 2023 Net Income $ 15,965 $ 15,844 $ 49,626 $ 22,256 Add Back:      Income Tax Expense  3,445 6,908 16,531 15,478      Interest Expense, net 4,710 3,368 11,956 9,444      Depreciation and Amortization  12,351 12,516 38,742 38,354 Adjustments:      Restructuring Expenses, net  2,662 1,099 12,342 3,412      Unrealized Currency Loss (Gain)  8,604 (898 ) 6,251 4,227      Acquisition and Integration Expenses ─ 1,618 ─ 4,730      Non-Automotive Electronics Inventory (Benefit) Charge (2,679 ) 3,426 (4,451 ) 5,489 Impairment of Goodwill ─ ─ ─ 19,509     Non-Cash Stock Based Compensation 2,927 3,421 10,334 8,592 Other 118 372 187 71 Adjusted EBITDA  $ 48,103 $ 47,674 $ 141,518 $ 131,562 Product Revenues $ 371,512 $ 366,195 $ 1,103,210 $ 1,102,143 Net Income Margin 4.3 % 4.3 % 4.5 % 2.0 % Adjusted EBITDA Margin 12.9 % 13.0 % 12.8 % 11.9 % Nine Months Ended September 30


Slide 14

Proprietary © Gentherm 2024 14 Reconciliation of Adjusted EPS 2024 2023 2024 2023 Diluted EPS - As Reported $ 0.51 $ 0.48 $ 1.57 $ 0.67 Acquisition and Integration Expenses ─ 0.05 ─ 0.14 Non-Cash Purchase Accounting Impacts 0.05 0.05 0.15 0.17 Unrealized Currency Loss (Gain)  0.27 (0.03 ) 0.20 0.13 Restructuring Expenses, net 0.08 0.03 0.39 0.10 Non-Automotive Electronics Inventory (Benefit) Charge (0.09 ) 0.10 (0.14 ) 0.16 Impairment of Goodwill ─ ─ ─ 0.59 Other ─ (0.01 ) 0.01 ─ Tax Effect of Above (0.09 ) (0.05 ) (0.14 ) (0.26 ) Rounding 0.02 ─ (0.01 ) 0.01 Diluted EPS - As Adjusted $ 0.75 $ 0.64 $ 2.03 $ 1.71 Three Months Ended September 30 Nine Months Ended September 30

v3.24.3
Document And Entity Information
Oct. 30, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 30, 2024
Entity Registrant Name GENTHERM INCORPORATED
Entity Central Index Key 0000903129
Entity Emerging Growth Company false
Entity File Number 0-21810
Entity Incorporation, State or Country Code MI
Entity Tax Identification Number 95-4318554
Entity Address, Address Line One 21680 Haggerty Road
Entity Address, City or Town Northville
Entity Address, State or Province MI
Entity Address, Postal Zip Code 48167
City Area Code (248)
Local Phone Number 504-0500
Entity Information, Former Legal or Registered Name N/A
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, no par value
Trading Symbol THRM
Security Exchange Name NASDAQ

Gentherm (NASDAQ:THRM)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Gentherm Charts.
Gentherm (NASDAQ:THRM)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Gentherm Charts.